Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

IMV Inc
Bullboard Posts
User Avatar Image
(77)
•••
Comment by GorgeousGeorge1on Jun 13, 2018 3:34pm
110 Views
Post# 28167620

RE:RE:RE:RE:RE:RE:RE:Price action annoying today

RE:RE:RE:RE:RE:RE:RE:Price action annoying todayHi PoorOpinion, speaking of comparative companies, I was wondering if you (or any of the other knowledgeable followers) might share your thoughts on any direct competition to us? Our tech is pretty unique and is complimentary to drugs being developed across numerous targets, does that sound like a fair statement? Is there anybody else worth watching that may be a threat? Any thoughts appreciated.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities